GW842166X

DRUG3 trials

Sponsors

GlaxoSmithKline

Conditions

Healthy SubjectsPain, Inflammatory

Phase 1

An Imaging Study to Investigate the Distribution of GW842166X in the Brain.

CompletedNCT00511524

GlaxoSmithKlinePain, Inflammatory

Start: 2007-06-26End: 2007-07-04Updated: 2017-08-07

Relative Bioavailability Study on a Single Dose of GW842166X in Healthy Male and Female Subjects.

WithdrawnNCT00536497

GlaxoSmithKlineHealthy Subjects

Start: 2007-09-30Updated: 2015-02-16

Dose Response and Efficacy of GW842166 in Pain

WithdrawnNCT00554762

GlaxoSmithKlineHealthy Subjects

Start: 2007-11-30End: 2008-03-31Updated: 2015-02-16